What is the evidence to support the use of plasma exchange as first-line therapy for N-methyl d-aspartate receptor antibody encephalitis?
J Clin Apher
.
2018 Feb;33(1):126-127.
doi: 10.1002/jca.21567.
Epub 2017 Jul 12.
Authors
Eric A Gehrie
1
,
Emily A Coberly
2
,
Angela Treml
3
,
Christopher Tormey
4
5
,
Garrett S Booth
6
Affiliations
1
Department of Pathology, Johns Hopkins University, Baltimore, Maryland.
2
Department of Pathology, University of Missouri, Columbia, Missouri.
3
Department of Pathology, The University of Chicago, Chicago, Illinois.
4
Department of Laboratory Medicine, Yale University, New Haven, Connecticut.
5
Department of Pathology and Laboratory Medicine, VA Connecticut, West Haven, Connecticut.
6
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
PMID:
28699649
DOI:
10.1002/jca.21567
No abstract available
Publication types
Letter
MeSH terms
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / therapy*
Autoantibodies
Evidence-Based Medicine / trends
Female
Humans
Plasma Exchange / methods*
Substances
Autoantibodies